| The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ... Nature 486 (7403), 346-352, 2012 | 5916 | 2012 |
| The clonal and mutational evolution spectrum of primary triple-negative breast cancers SP Shah, A Roth, R Goya, A Oloumi, G Ha, Y Zhao, G Turashvili, J Ding, ... Nature 486 (7403), 395-399, 2012 | 2269 | 2012 |
| The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 1911 | 2012 |
| ARID1A Mutations in Endometriosis-Associated Ovarian Carcinomas KC Wiegand, SP Shah, OM Al-Agha, Y Zhao, K Tse, T Zeng, J Senz, ... New England Journal of Medicine 363 (16), 1532-1543, 2010 | 1897 | 2010 |
| The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes B Pereira, SF Chin, OM Rueda, HKM Vollan, E Provenzano, HA Bardwell, ... Nature communications 7 (1), 1-16, 2016 | 1543 | 2016 |
| Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution SP Shah, RD Morin, J Khattra, L Prentice, T Pugh, A Burleigh, A Delaney, ... Nature 461 (7265), 809-813, 2009 | 1320 | 2009 |
| Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary SP Shah, M Köbel, J Senz, RD Morin, BA Clarke, KC Wiegand, G Leung, ... New England Journal of Medicine 360 (26), 2719-2729, 2009 | 854 | 2009 |
| Tumor heterogeneity in breast cancer G Turashvili, E Brogi Frontiers in medicine 4, 227, 2017 | 573 | 2017 |
| The shaping and functional consequences of the microRNA landscape in breast cancer H Dvinge, A Git, S Gräf, M Salmon-Divon, C Curtis, A Sottoriva, Y Zhao, ... Nature 497 (7449), 378-382, 2013 | 472 | 2013 |
| Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis G Turashvili, J Bouchal, K Baumforth, W Wei, M Dziechciarkova, ... BMC cancer 7, 1-20, 2007 | 470 | 2007 |
| Quantitative image analysis of cellular heterogeneity in breast tumors complements genomic profiling Y Yuan, H Failmezger, OM Rueda, HR Ali, S Gräf, SF Chin, RF Schwarz, ... Science translational medicine 4 (157), 157ra143-157ra143, 2012 | 462 | 2012 |
| A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability P Eirew, J Stingl, A Raouf, G Turashvili, S Aparicio, JT Emerman, ... Nature medicine 14 (12), 1384-1389, 2008 | 385 | 2008 |
| BCL2 in breast cancer: a favourable prognostic marker across molecular subtypes and independent of adjuvant therapy received SJ Dawson, N Makretsov, FM Blows, KE Driver, E Provenzano, ... British journal of cancer 103 (5), 668-675, 2010 | 367 | 2010 |
| Integrative analysis of genome-wide loss of heterozygosity and monoallelic expression at nucleotide resolution reveals disrupted pathways in triple-negative breast cancer G Ha, A Roth, D Lai, A Bashashati, J Ding, R Goya, R Giuliany, J Rosner, ... Genome research 22 (10), 1995-2007, 2012 | 308 | 2012 |
| Wnt signaling pathway in mammary gland development and carcinogenesis G Turashvili, J Bouchal, G Burkadze, Z Kolar Pathobiology 73 (5), 213-223, 2007 | 246 | 2007 |
| JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data A Roth, J Ding, R Morin, A Crisan, G Ha, R Giuliany, A Bashashati, M Hirst, ... Bioinformatics 28 (7), 907-913, 2012 | 233 | 2012 |
| Langerød A C Curtis, SP Shah, SF Chin, G Turashvili, OM Rueda, MJ Dunning, ... Green A, Provenzano E, Wishart G, Pinder S, Watson P, Markowetz F, Murphy L …, 2012 | 233 | 2012 |
| Oslo Breast Cancer Consortium (OSBREAC). The landscape of cancer genes and mutational processes in breast cancer PJ Stephens, PS Tarpey, H Davies, P Van Loo, C Greenman, DC Wedge, ... Nature 486 (7403), 400-404, 2012 | 191 | 2012 |
| Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes R Yerushalmi, KA Gelmon, S Leung, D Gao, M Cheang, M Pollak, ... Breast cancer research and treatment 132, 131-142, 2012 | 169 | 2012 |
| Assessment of sentinel lymph node biopsy vs lymphadenectomy for intermediate-and high-grade endometrial cancer staging MC Cusimano, D Vicus, K Pulman, M Maganti, MQ Bernardini, ... JAMA surgery 156 (2), 157-164, 2021 | 162 | 2021 |
